Premier Alternatives

MedGenome Labs

Bangalore, India · Founded 2013 · Privately Held (backing)

Developer of sequencing genomics-based diagnostics and research platform intended for patients, pharmaceutical companies, and research institutions around the world. MedGenome Labs is based in Bangalore, India and was founded in 2013. Its last reported valuation was $603 million in Jul 2025. It has raised $223 million.

Last reported valuation
$603.0M
Oct 2026
Priced at
—
Total raised
$222.9M
Last round
—

MedGenome Labs key facts

as of Oct 2026
  • Developer of sequencing genomics-based diagnostics and research platform intended for patients, pharmaceutical companies, and research institutions around the world.
  • MedGenome Labs is valued at approximately $603.0M as of Oct 2026 (last reported valuation).
  • It has raised $222.9M; the latest was Later Stage VC ($47.5M) in Jul 2025.
  • Notable investors include Peak XV Partners, International Finance (Washington D.C.), Novo Holdings, ATEL Capital Group, Sofina — 16 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$603.0M

MedGenome Labs's last reported valuation, Jul 2025. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of MedGenome Labs with a free account
  • ·The complete investor list: 16 names
  • ·Watch MedGenome Labs: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

MedGenome Labs funding rounds

No rounds on record

No funding rounds for MedGenome Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

MedGenome Labs valuation

MedGenome Labs's last reported valuation was $603 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.

MedGenome Labs investors

16 investors are on record for MedGenome Labs, including Peak XV Partners, International Finance (Washington D.C.), Novo Holdings and ATEL Capital Group.

About MedGenome Labs

Developer of sequencing genomics-based diagnostics and research platform intended for patients, pharmaceutical companies, and research institutions around the world. The company's platform applies genomics technologies, bioinformatics, computing and big data analytics to the genetically diverse and large population to understand the genetic basis of cancer, metabolic disorders, eye disorders and other rare diseases, and offers high-end genetic diagnostic tests across various disease categories; immuno-oncology, infectious diseases, reproductive health and rare diseases, enabling the healthcare industry to develop deep insights into diseases at the genetic and molecular level.

Sector
Healthcare
HQ
Bangalore, India
Founded
2013
Employees
1,000
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.